Skip to main navigation
Skip to search
Skip to main content
Discovery - the University of Dundee Research Portal Home
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Search by expertise, name or affiliation
Pharmacogenetics of sulfonylureas
Peter Kovacs (Lead / Corresponding author)
,
Ewan Pearson
(Lead / Corresponding author)
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacogenetics of sulfonylureas'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Sulfonylurea
100%
Pharmacogenetics
100%
Type 2 Diabetes Mellitus (T2DM)
62%
KCNJ11
25%
Monogenic Diabetes
25%
ABCC8
25%
Pharmacogenomics
25%
Collaborative Efforts
12%
Diabetes
12%
Recent Advances
12%
Between-person
12%
Molecular Biology
12%
Clinical Practice
12%
Clinical Application
12%
Genetic Variants
12%
Cytochrome P450 Enzymes
12%
Type 2 Diabetes Risk
12%
Transcription Factor 7-like 2 (TCF7L2)
12%
Molecular Genetics
12%
SUR1
12%
Kir6.2
12%
Neonatal Diabetes
12%
Population-based Study
12%
Pharmacodynamics
12%
Gene Variants
12%
CYP2C9
12%
Patient Health
12%
Monogenic
12%
Patient Subgroups
12%
HNF1A-MODY
12%
Drug Action
12%
Pharmacokinetic Variability
12%
Oral Antidiabetic Drugs
12%
Potassium Channel Genes
12%
Biochemistry, Genetics and Molecular Biology
Sulfonylurea
100%
Pharmacogenetics
100%
ABCC8
25%
Pharmacogenomics
25%
Pharmacodynamics
12%
Pharmacokinetics
12%
Molecular Biology
12%
Potassium Channel
12%
Kir6.2
12%
Molecular Genetics
12%
Genetic Divergence
12%
CYP2C9
12%
TCF7L2
12%
Hope
12%
HNF1A
12%
Population Research
12%
Isoenzyme
12%
Drug Mechanism
12%
Cytochrome P450
12%
Neuroscience
Sulfonylurea
100%
Potassium Channel
12%
Kir6.2
12%
Cytochrome P450 2C9
12%
TCF7L2
12%
HNF1A
12%
Cytochrome P450 Isoenzyme
12%
Pharmacokinetics
12%